<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="https://rss.buzzsprout.com/styles.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:psc="http://podlove.org/simple-chapters" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <atom:link href="https://rss.buzzsprout.com/2039560.rss" rel="self" type="application/rss+xml" />
  <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub" xmlns="http://www.w3.org/2005/Atom" />
  <title>Pharma Sessions</title>

  <lastBuildDate>Thu, 21 May 2026 09:48:03 -0400</lastBuildDate>
  <link>https://podcasts.fame.so/pharma-sessions</link>
  <language>en-us</language>
  <copyright>© 2026 Pharma Sessions</copyright>
  <podcast:locked>yes</podcast:locked>
    <podcast:guid>49ecc15d-4fc2-5b64-aad5-bbbfed5eccb5</podcast:guid>
  <itunes:author>Jonathan Kaskey</itunes:author>
  <itunes:type>episodic</itunes:type>
  <itunes:explicit>false</itunes:explicit>
  <description><![CDATA[Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)]]></description>
  <generator>Buzzsprout (https://www.buzzsprout.com)</generator>
  <itunes:owner>
    <itunes:name>Jonathan Kaskey</itunes:name>
  </itunes:owner>
  <image>
     <url>https://storage.buzzsprout.com/evh90wqgnacp11p8ifzhlspfgopu?.jpg</url>
     <title>Pharma Sessions</title>
     <link>https://podcasts.fame.so/pharma-sessions</link>
  </image>
  <itunes:image href="https://storage.buzzsprout.com/evh90wqgnacp11p8ifzhlspfgopu?.jpg" />
  <itunes:category text="Health &amp; Fitness">
    <itunes:category text="Medicine" />
  </itunes:category>
  <itunes:category text="Business">
    <itunes:category text="Medicine" />
  </itunes:category>
  <itunes:category text="Science">
    <itunes:category text="Life Sciences" />
  </itunes:category>
  <item>
    <itunes:title>Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury</itunes:title>
    <title>Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy's and St Thomas' NHS Foundation Trust, to talk about Open Medicine, a platform designed to take what’s inside the minds of the world’s leading oncologists and make it accessible to any clinician on a mobile phone. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content sha...]]></itunes:summary>
    <description><![CDATA[<p>In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy&apos;s and St Thomas&apos; NHS Foundation Trust, to talk about Open Medicine, a platform designed to take what’s inside the minds of the world’s leading oncologists and make it accessible to any clinician on a mobile phone.</p><p><em>Pharma Sessions</em> provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.</p><p>The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.</p><p>Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.</p> <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[<p>In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy&apos;s and St Thomas&apos; NHS Foundation Trust, to talk about Open Medicine, a platform designed to take what’s inside the minds of the world’s leading oncologists and make it accessible to any clinician on a mobile phone.</p><p><em>Pharma Sessions</em> provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.</p><p>The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.</p><p>Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.</p> <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19215524-why-medical-knowledge-isn-t-reaching-patients-with-dr-simon-chowdhury.mp3" length="26468317" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/42sljhnobqsk6m8t7owlll8z9doz?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">Buzzsprout-19215524</guid>
    <pubDate>Thu, 21 May 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19215524/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19215524/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19215524/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19215524/transcript.vtt" type="text/vtt" />
    <itunes:duration>2202</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>31</itunes:episode>
    <itunes:episodeType>full</itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Timothy Smith on AI, Data, and Drug Discovery at Takeda</itunes:title>
    <title>Timothy Smith on AI, Data, and Drug Discovery at Takeda</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust and governance are still major hurdles, and why the biggest bottleneck in pharma innovation might not be technology but people.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with it...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust and governance are still major hurdles, and why the biggest bottleneck in pharma innovation might not be technology but people.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust and governance are still major hurdles, and why the biggest bottleneck in pharma innovation might not be technology but people.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196174-timothy-smith-on-ai-data-and-drug-discovery-at-takeda.mp3" length="23513138" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/fyxpiruwrtu98p9vovnevzsrbf3k?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80x2vrx0</guid>
    <pubDate>Thu, 14 May 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196174/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196174/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196174/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196174/transcript.vtt" type="text/vtt" />
    <itunes:duration>1955</itunes:duration>
    <itunes:keywords>AI in pharma, Pharmaceutical AI, Generative AI in healthcare, Machine learning in pharma, AI adoption in healthcare, Data science in pharma, AI innovation in pharma, Drug discovery AI, Enterprise AI transformation, AI in pharmaceutical R&amp;D  Select 64 more</itunes:keywords>
    <itunes:episode>30</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Lessons on Leading Through Uncertainty in Pharma</itunes:title>
    <title>Lessons on Leading Through Uncertainty in Pharma</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196175-lessons-on-leading-through-uncertainty-in-pharma.mp3" length="26101886" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/bn5hvn2rvin48t0wx0vsuiquf1sz?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81znzn21</guid>
    <pubDate>Thu, 07 May 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196175/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196175/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196175/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196175/transcript.vtt" type="text/vtt" />
    <itunes:duration>2171</itunes:duration>
    <itunes:keywords>AI in healthcare, medical affairs leadership, pharmaceutical industry, AI in pharma, augmented intelligence, medical affairs strategy, healthcare innovation, real world evidence, pharma leadership, AI and patient care</itunes:keywords>
    <itunes:episode>29</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Where AI Delivers Real Value in Pharma Today with Emily Lewis</itunes:title>
    <title>Where AI Delivers Real Value in Pharma Today with Emily Lewis</title>
    <itunes:summary><![CDATA[Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy ...]]></itunes:summary>
    <description><![CDATA[Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy across your organization, and the regulatory workflows where AI will deliver impact fastest.

Disclaimer: Pharma Sessions is for informational purposes only and does not constitute medical, legal, or financial advice. Guest opinions are their own and do not reflect the views of the host or sponsors. Use of any information provided is at the listener’s own risk and does not imply endorsement of specific products or strategies. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity.

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy across your organization, and the regulatory workflows where AI will deliver impact fastest.

Disclaimer: Pharma Sessions is for informational purposes only and does not constitute medical, legal, or financial advice. Guest opinions are their own and do not reflect the views of the host or sponsors. Use of any information provided is at the listener’s own risk and does not imply endorsement of specific products or strategies. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196189-where-ai-delivers-real-value-in-pharma-today-with-emily-lewis.mp3" length="23699864" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/ro6axxl4mxqj7rud8tzajwbugggh?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81nv37r1</guid>
    <pubDate>Thu, 30 Apr 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196189/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196189/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196189/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196189/transcript.vtt" type="text/vtt" />
    <itunes:duration>1971</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>28</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How Medical Affairs Becomes the Connector with Sonia Talwar</itunes:title>
    <title>How Medical Affairs Becomes the Connector with Sonia Talwar</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informati...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196190-how-medical-affairs-becomes-the-connector-with-sonia-talwar.mp3" length="18704596" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/xtlebi54aia394c00tt3t5d19lu8?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">70wj3nz1</guid>
    <pubDate>Thu, 23 Apr 2026 09:29:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196190/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196190/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196190/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196190/transcript.vtt" type="text/vtt" />
    <itunes:duration>1531</itunes:duration>
    <itunes:keywords>Jonathan Kaskey, Pharma Sessions podcast ,medical affairs strategy, pharmaceutical industry insights, healthcare data analytics, evidence strategy pharma, real world evidence healthcare, HCP engagement pharma, scientific communications pharma, medical inf</itunes:keywords>
    <itunes:episode>27</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy</itunes:title>
    <title>Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine.
Pharma Sessions provides general insights into the pharmaceutical and life science...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196191-why-manufacturing-is-the-new-competitive-edge-in-cell-and-gene-therapy.mp3" length="23526090" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/meuhglb9l39iczlwvr1vjy6wwg2d?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">21996621</guid>
    <pubDate>Thu, 16 Apr 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196191/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196191/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196191/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196191/transcript.vtt" type="text/vtt" />
    <itunes:duration>1956</itunes:duration>
    <itunes:keywords>Eytan Abraham, Jonathan Kaskey, Pharma Sessions podcast, CDMO selection, cell and gene therapy manufacturing, Minaris Advanced Therapies, biotech manufacturing strategy, advanced therapies industry, CAR-T therapy cost, pharmaceutical manufacturing innovat</itunes:keywords>
    <itunes:episode>26</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2</itunes:title>
    <title>The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podc...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.

Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.

The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.

Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196192-the-future-of-healthcare-with-dr-david-shulkin-former-secretary-of-the-united-states-department-of-veterans-affairs-part-2.mp3" length="15369797" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/y8i7e7dbuko8qwvqoyj5ycfggmgt?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">j12rlxr1</guid>
    <pubDate>Thu, 09 Apr 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196192/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196192/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196192/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196192/transcript.vtt" type="text/vtt" />
    <itunes:duration>1276</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>25</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1</itunes:title>
    <title>The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of policy and care delivery, the role of innovation and technology, and what must change to better serve patients.
Pharma Sessions provides general insights into the pharmaceutical and life sciences indus...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of policy and care delivery, the role of innovation and technology, and what must change to better serve patients.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of policy and care delivery, the role of innovation and technology, and what must change to better serve patients.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196193-the-future-of-healthcare-with-dr-david-shulkin-former-secretary-of-the-united-states-department-of-veterans-affairs-part-1.mp3" length="23076375" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/ni0s74dvupqb1uhi1ryuelnksdu0?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81q3x6w1</guid>
    <pubDate>Thu, 02 Apr 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196193/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196193/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196193/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196193/transcript.vtt" type="text/vtt" />
    <itunes:duration>1919</itunes:duration>
    <itunes:keywords>Pharma Sessions Podcast, VA Healthcare System, Healthcare Leadership , Shulkin Solutions,  Veterans Affairs healthcare system</itunes:keywords>
    <itunes:episode>24</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar</itunes:title>
    <title>How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable.
Pharma Sessions provides general insights into the pharmaceutica...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196194-how-ai-is-reshaping-pharma-s-commercial-operations-with-punit-kumar.mp3" length="28410949" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/luk9wi2ujbxq5wl4dowubytkmnkp?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">x0l6m880</guid>
    <pubDate>Thu, 26 Mar 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196194/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196194/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196194/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196194/transcript.vtt" type="text/vtt" />
    <itunes:duration>2363</itunes:duration>
    <itunes:keywords>AI in pharma, AI agents in healthcare, Pharma execution excellence,  Pharma launch strategy, Pharma Podcast, Pharma Leadership</itunes:keywords>
    <itunes:episode>23</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why Pharma products win or lose years before launch</itunes:title>
    <title>Why Pharma products win or lose years before launch</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Procter &amp; Gamble, Pfizer, and biotech.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and shoul...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Procter &amp; Gamble, Pfizer, and biotech.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Procter &amp; Gamble, Pfizer, and biotech.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196195-why-pharma-products-win-or-lose-years-before-launch.mp3" length="23415488" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/e2ndbhk685e7pdf3ej9i5spwz77w?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80nvr680</guid>
    <pubDate>Thu, 19 Mar 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196195/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196195/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196195/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196195/transcript.vtt" type="text/vtt" />
    <itunes:duration>1947</itunes:duration>
    <itunes:keywords>AI in pharmaceutical marketing, digital health adoption, pharmaceutical commercial strategy, biotech career transition, Pharma Sessions Podcast , Pharmaceutical Commercial Strategy , Biotech Career Transition, Farrell Simon , Trevi Therapeutics</itunes:keywords>
    <itunes:episode>22</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth</itunes:title>
    <title>Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth</title>
    <itunes:summary><![CDATA[Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strat...]]></itunes:summary>
    <description><![CDATA[Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strategy, why investing in rigorous clinical trials can be a defining leadership decision, and why face-to-face relationships remain essential for market adoption in healthcare.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strategy, why investing in rigorous clinical trials can be a defining leadership decision, and why face-to-face relationships remain essential for market adoption in healthcare.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196196-building-a-cancer-medtech-company-the-hard-way-shaun-bagai-on-evidence-strategy-and-growth.mp3" length="23563262" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/zinc08p2l1o7xwxcjgp8xx7n5srr?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71yp2pv0</guid>
    <pubDate>Thu, 12 Mar 2026 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196196/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196196/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196196/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196196/transcript.vtt" type="text/vtt" />
    <itunes:duration>1959</itunes:duration>
    <itunes:keywords>Shaun Bagai,  pharmaceutical commercialization,  pharma CEO insights,  CEO leadership, cancer care advancement, commercial leadership, biotech company scaling</itunes:keywords>
    <itunes:episode>21</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How to Actually Get the Stuff You Want Approved in Pharma</itunes:title>
    <title>How to Actually Get the Stuff You Want Approved in Pharma</title>
    <itunes:summary><![CDATA[In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again.Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or jo...]]></itunes:summary>
    <description><![CDATA[In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196197-how-to-actually-get-the-stuff-you-want-approved-in-pharma.mp3" length="11818075" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/fat5fjw80mw7ru2mht5fjaqb48eq?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">40pqr491</guid>
    <pubDate>Thu, 05 Mar 2026 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196197/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196197/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196197/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196197/transcript.vtt" type="text/vtt" />
    <itunes:duration>981</itunes:duration>
    <itunes:keywords>pharma software adoption, technology implementation, Jonathan Kaskey , AI-powered reporting pharma, pharma digital transformation trends</itunes:keywords>
    <itunes:episode>20</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko</itunes:title>
    <title>How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko</title>
    <itunes:summary><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.
Pharma Sessions provides gene...]]></itunes:summary>
    <description><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196198-how-skinpass-went-from-bedside-insight-to-retail-scale-with-dr-christopher-otiko.mp3" length="19381896" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/mg7e00j9dv3kbv0q888wvn2345tu?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">l04r6mm0</guid>
    <pubDate>Thu, 26 Feb 2026 12:36:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196198/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196198/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196198/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196198/transcript.vtt" type="text/vtt" />
    <itunes:duration>1611</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>19</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why Drug Launches Are Won Years Before Approval with Ana Bozas</itunes:title>
    <title>Why Drug Launches Are Won Years Before Approval with Ana Bozas</title>
    <itunes:summary><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. Pharma Sessions is hosted by ...]]></itunes:summary>
    <description><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific  Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196199-why-drug-launches-are-won-years-before-approval-with-ana-bozas.mp3" length="22132347" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/8kvy86omfr8ncxke2yic0v2d3g9o?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71wj5v50</guid>
    <pubDate>Thu, 19 Feb 2026 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196199/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196199/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196199/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196199/transcript.vtt" type="text/vtt" />
    <itunes:duration>1840</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>18</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Building AI Workflows That Actually Work in Pharma with Adam Mico</itunes:title>
    <title>Building AI Workflows That Actually Work in Pharma with Adam Mico</title>
    <itunes:summary><![CDATA[Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proofing really looks like when AI lowers the barrier to building dashboards, writing code, and generating insights. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Session...]]></itunes:summary>
    <description><![CDATA[Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proofing really looks like when AI lowers the barrier to building dashboards, writing code, and generating insights. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proofing really looks like when AI lowers the barrier to building dashboards, writing code, and generating insights. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196200-building-ai-workflows-that-actually-work-in-pharma-with-adam-mico.mp3" length="24746252" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/a2aps6va6cvyz53ep3ljodl0nyzo?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71wj56p0</guid>
    <pubDate>Thu, 12 Feb 2026 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196200/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196200/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196200/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196200/transcript.vtt" type="text/vtt" />
    <itunes:duration>2058</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>17</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why AI Pilots Fail in Pharma, And Why Yours Won’t with Jeremy Zhang</itunes:title>
    <title>Why AI Pilots Fail in Pharma, And Why Yours Won’t with Jeremy Zhang</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com   ]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196201-why-ai-pilots-fail-in-pharma-and-why-yours-won-t-with-jeremy-zhang.mp3" length="24745058" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/8bd31741wfpjwmn3bwbi56gzst1g?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">713r84j0</guid>
    <pubDate>Fri, 30 Jan 2026 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196201/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196201/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196201/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196201/transcript.vtt" type="text/vtt" />
    <itunes:duration>2058</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>15</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Medical Affairs AI &amp; Omnichannel Strategy: How to Earn Trust and Attention</itunes:title>
    <title>Medical Affairs AI &amp; Omnichannel Strategy: How to Earn Trust and Attention</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs' needs through omnichannel communication strategies, accessible and engaging scientific data, and technology-enabled solutions like digital microsites and AI analysis. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs&apos; needs through omnichannel communication strategies, accessible and engaging scientific data, and technology-enabled solutions like digital microsites and AI analysis. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs&apos; needs through omnichannel communication strategies, accessible and engaging scientific data, and technology-enabled solutions like digital microsites and AI analysis. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196202-medical-affairs-ai-omnichannel-strategy-how-to-earn-trust-and-attention.mp3" length="25016595" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/v11narlbmcm0znnmnrjxtz5mqpug?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">815rxxw0</guid>
    <pubDate>Thu, 22 Jan 2026 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196202/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196202/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196202/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196202/transcript.vtt" type="text/vtt" />
    <itunes:duration>2080</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>14</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Sales Leadership Mastery: People + Tech</itunes:title>
    <title>Sales Leadership Mastery: People + Tech</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great selling and sustainable revenue growth. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com   ]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great selling and sustainable revenue growth. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great selling and sustainable revenue growth. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196203-sales-leadership-mastery-people-tech.mp3" length="22364054" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/3dhawscceioczno4wb09qq5se5zo?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">40pqpw31</guid>
    <pubDate>Thu, 15 Jan 2026 11:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196203/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196203/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196203/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196203/transcript.vtt" type="text/vtt" />
    <itunes:duration>1860</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>13</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Scientific Storytelling and Omnichannel Strategy in Modern Medical Affairs</itunes:title>
    <title>Scientific Storytelling and Omnichannel Strategy in Modern Medical Affairs</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications &amp; Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnichannel strategy to amplify impact, and help brands stand out in highly competitive markets.\ Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www....]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications &amp; Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnichannel strategy to amplify impact, and help brands stand out in highly competitive markets.\ <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications &amp; Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnichannel strategy to amplify impact, and help brands stand out in highly competitive markets.\ <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196204-scientific-storytelling-and-omnichannel-strategy-in-modern-medical-affairs.mp3" length="20770143" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/9d9frz6u768y9uvk5qryxf3iosd3?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">70wj4wn1</guid>
    <pubDate>Thu, 08 Jan 2026 13:13:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196204/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196204/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196204/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196204/transcript.vtt" type="text/vtt" />
    <itunes:duration>1726</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>New Direction: Career Pivots, Niche AI, and the Future of Pharma Sessions</itunes:title>
    <title>New Direction: Career Pivots, Niche AI, and the Future of Pharma Sessions</title>
    <itunes:summary><![CDATA[In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all.
Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driv...]]></itunes:summary>
    <description><![CDATA[In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all.
Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driving force behind his next chapter. Along the way, he reflects on what AI should be doing in pharma, why niche, domain-specific tools outperform generic platforms, and how teams can move beyond manual reporting toward real strategic impact.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all.
Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driving force behind his next chapter. Along the way, he reflects on what AI should be doing in pharma, why niche, domain-specific tools outperform generic platforms, and how teams can move beyond manual reporting toward real strategic impact.<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196205-new-direction-career-pivots-niche-ai-and-the-future-of-pharma-sessions.mp3" length="13020374" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/rvwm6yy2mdl62ly3ztfuh2l9sojr?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">2199xkr1</guid>
    <pubDate>Thu, 18 Dec 2025 13:03:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196205/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196205/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196205/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196205/transcript.vtt" type="text/vtt" />
    <itunes:duration>1082</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>11</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Martin McLaughlin’s Four-Pillar Playbook to Launching Better, Faster, and Smarter</itunes:title>
    <title>Martin McLaughlin’s Four-Pillar Playbook to Launching Better, Faster, and Smarter</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com   ]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196206-martin-mclaughlin-s-four-pillar-playbook-to-launching-better-faster-and-smarter.mp3" length="22030519" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/blr73xs0l6vs3oqbkdrkq07l7e9i?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">l14rpz31</guid>
    <pubDate>Thu, 04 Dec 2025 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196206/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196206/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196206/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196206/transcript.vtt" type="text/vtt" />
    <itunes:duration>1832</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>10</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>What Happens When Pharma Starts Listening?</itunes:title>
    <title>What Happens When Pharma Starts Listening?</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharm...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196207-what-happens-when-pharma-starts-listening.mp3" length="20572984" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/ruw7hlbna6ng3tne29s0w0xdduj4?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">j02rjxw0</guid>
    <pubDate>Thu, 13 Nov 2025 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196207/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196207/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196207/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196207/transcript.vtt" type="text/vtt" />
    <itunes:duration>1710</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>9</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How Shionogi&#39;s VP Turns Data into Commercial Success</itunes:title>
    <title>How Shionogi&#39;s VP Turns Data into Commercial Success</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Sub...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196208-how-shionogi-s-vp-turns-data-into-commercial-success.mp3" length="23644669" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/8ludyb3f5twy2pj8pdvomq56codo?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">v17rjmw0</guid>
    <pubDate>Thu, 30 Oct 2025 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196208/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196208/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196208/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196208/transcript.vtt" type="text/vtt" />
    <itunes:duration>1966</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>8</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>How Caitlyn Krebs Built an AI Engine That Designs Drugs 5x Faster</itunes:title>
    <title>How Caitlyn Krebs Built an AI Engine That Designs Drugs 5x Faster</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health. Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com   ]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196209-how-caitlyn-krebs-built-an-ai-engine-that-designs-drugs-5x-faster.mp3" length="24432685" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/r8wafnt80f711dt70y1mvselhiqo?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">61mk85w1</guid>
    <pubDate>Thu, 16 Oct 2025 09:04:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196209/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196209/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196209/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196209/transcript.vtt" type="text/vtt" />
    <itunes:duration>2032</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>7</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Advice From the Frontlines of Pharma: Holistic Healthcare, The Opioid Crisis &amp; Remote-Work in Pharma</itunes:title>
    <title>Advice From the Frontlines of Pharma: Holistic Healthcare, The Opioid Crisis &amp; Remote-Work in Pharma</title>
    <itunes:summary><![CDATA[This episode of Pharma Sessions is much like a pharmacy - it has something for everyone. Tune in as we reflect on critical conversations hosted by Jonathan Kaskey, so far in the series. Whether it’s critical pathways into pharma careers, the opioid crisis, and work-life balance in the modern pharmaceutical industry, this recap explores it all. From transitioning into MSL roles to building diverse medical teams, guests share practical strategies for career advancement and cross-functional coll...]]></itunes:summary>
    <description><![CDATA[This episode of Pharma Sessions is much like a pharmacy - it has something for everyone. Tune in as we reflect on critical conversations hosted by Jonathan Kaskey, so far in the series. Whether it’s critical pathways into pharma careers, the opioid crisis, and work-life balance in the modern pharmaceutical industry, this recap explores it all. From transitioning into MSL roles to building diverse medical teams, guests share practical strategies for career advancement and cross-functional collaboration, offering valuable insights on medical affairs leadership, risk mitigation in pain management, and creating boundaries while working remotely.

Think of this as the playbook for pharmaceutical professionals looking to navigate industry challenges and advance their careers. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[This episode of Pharma Sessions is much like a pharmacy - it has something for everyone. Tune in as we reflect on critical conversations hosted by Jonathan Kaskey, so far in the series. Whether it’s critical pathways into pharma careers, the opioid crisis, and work-life balance in the modern pharmaceutical industry, this recap explores it all. From transitioning into MSL roles to building diverse medical teams, guests share practical strategies for career advancement and cross-functional collaboration, offering valuable insights on medical affairs leadership, risk mitigation in pain management, and creating boundaries while working remotely.

Think of this as the playbook for pharmaceutical professionals looking to navigate industry challenges and advance their careers. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196210-advice-from-the-frontlines-of-pharma-holistic-healthcare-the-opioid-crisis-remote-work-in-pharma.mp3" length="23059537" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/f54wdgmdtqt4hfazidag8sj4keoy?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81x2w9w1</guid>
    <pubDate>Thu, 25 Sep 2025 10:54:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196210/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196210/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196210/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196210/transcript.vtt" type="text/vtt" />
    <itunes:duration>1917</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>6</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Speed is the Need: Launch strategy with Hetal Patel</itunes:title>
    <title>Speed is the Need: Launch strategy with Hetal Patel</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Hetal Patel, VP of Medical Affairs at Celltrion USA, about building a medical affairs function from the ground up while launching multiple drugs. Sounds like a hot pot of pressure, decision-making and sleepless nights, doesn't it? Well, don’t let this intimidate you just yet. From transitioning out of big pharma to scaling systems with limited resources, Hetal shares practical strategies for thriving in high-pressure launch e...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Hetal Patel, VP of Medical Affairs at Celltrion USA, about building a medical affairs function from the ground up while launching multiple drugs. Sounds like a hot pot of pressure, decision-making and sleepless nights, doesn&apos;t it? Well, don’t let this intimidate you just yet. From transitioning out of big pharma to scaling systems with limited resources, Hetal shares practical strategies for thriving in high-pressure launch environments and how to do so without burning out. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Hetal Patel, VP of Medical Affairs at Celltrion USA, about building a medical affairs function from the ground up while launching multiple drugs. Sounds like a hot pot of pressure, decision-making and sleepless nights, doesn&apos;t it? Well, don’t let this intimidate you just yet. From transitioning out of big pharma to scaling systems with limited resources, Hetal shares practical strategies for thriving in high-pressure launch environments and how to do so without burning out. <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196211-speed-is-the-need-launch-strategy-with-hetal-patel.mp3" length="19582375" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/bipuul6mt6o3fvmtm5dv233v5u6u?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71v5wjw0</guid>
    <pubDate>Thu, 11 Sep 2025 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196211/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196211/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196211/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196211/transcript.vtt" type="text/vtt" />
    <itunes:duration>1628</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>5</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Beyond the Clinic: A Conversation with Dr. Adam Laitman, Director of Medical Affairs for Salix Pharmaceuticals</itunes:title>
    <title>Beyond the Clinic: A Conversation with Dr. Adam Laitman, Director of Medical Affairs for Salix Pharmaceuticals</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry.  Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be... P...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry.  Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry.  Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196212-beyond-the-clinic-a-conversation-with-dr-adam-laitman-director-of-medical-affairs-for-salix-pharmaceuticals.mp3" length="20417789" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/h9c8a9tel6el23adm3e98bivdvl3?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">k18yqy80</guid>
    <pubDate>Thu, 29 May 2025 08:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196212/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196212/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196212/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196212/transcript.vtt" type="text/vtt" />
    <itunes:duration>1698</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>4</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Breaking into Pharma with Emet Anceaume, Director of Field Medical Affairs at Immunovant</itunes:title>
    <title>Breaking into Pharma with Emet Anceaume, Director of Field Medical Affairs at Immunovant</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant.  Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot... P...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant.  Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant.  Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196213-breaking-into-pharma-with-emet-anceaume-director-of-field-medical-affairs-at-immunovant.mp3" length="22257137" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/4w52o9lbkifaldxte04wi333h9sv?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">z0r42450</guid>
    <pubDate>Mon, 14 Apr 2025 03:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196213/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196213/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196213/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196213/transcript.vtt" type="text/vtt" />
    <itunes:duration>1850</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>3</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Everyday is a New Puzzle with Vince Turner, Dir. Development Operations, Kite Pharma</itunes:title>
    <title>Everyday is a New Puzzle with Vince Turner, Dir. Development Operations, Kite Pharma</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince's career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members.  And stay to the end for the buttermilk pancakes recipe (courtesy of Mel... P...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince&apos;s career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members.  And stay to the end for the buttermilk pancakes recipe (courtesy of Mel... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince&apos;s career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members.  And stay to the end for the buttermilk pancakes recipe (courtesy of Mel... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196214-everyday-is-a-new-puzzle-with-vince-turner-dir-development-operations-kite-pharma.mp3" length="26448662" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/3lp9zr4lzgkmlgf55jqq91cw06q9?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81znqn81</guid>
    <pubDate>Mon, 17 Mar 2025 06:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196214/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196214/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196214/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196214/transcript.vtt" type="text/vtt" />
    <itunes:duration>2200</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals</itunes:title>
    <title>Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health.  They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks.  Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe's breakfast routine&amp;nb... Pharma Sessi...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health.  They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks.  Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe&apos;s breakfast routine&amp;nb... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health.  They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks.  Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe&apos;s breakfast routine&amp;nb... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196215-combining-tech-and-pharma-for-public-health-with-paul-howe-coo-of-protega-pharmaceuticals.mp3" length="23066873" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/vdhgulucxru3xs08evof1fiktwdn?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80x2z240</guid>
    <pubDate>Fri, 28 Feb 2025 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196215/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196215/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196215/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196215/transcript.vtt" type="text/vtt" />
    <itunes:duration>1918</itunes:duration>
    <itunes:keywords>pharma, pharmaceuticals, medical affairs, public health</itunes:keywords>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Bursting the Med Affairs Bubble with Dr. Samin Saeed, VP Early Medical Pipeline at GSK</itunes:title>
    <title>Bursting the Med Affairs Bubble with Dr. Samin Saeed, VP Early Medical Pipeline at GSK</title>
    <itunes:summary><![CDATA[Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration  In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h...]]></itunes:summary>
    <description><![CDATA[Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration  In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration  In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196216-bursting-the-med-affairs-bubble-with-dr-samin-saeed-vp-early-medical-pipeline-at-gsk.mp3" length="21719112" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/30bbg2npkk5fh0fefu4mx0rskz6c?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">x1l6j6m1</guid>
    <pubDate>Tue, 03 Dec 2024 03:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196216/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196216/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196216/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196216/transcript.vtt" type="text/vtt" />
    <itunes:duration>1806</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>11</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why Pharma needs Chiefs of Staff with Steve Cirillo-Thompson</itunes:title>
    <title>Why Pharma needs Chiefs of Staff with Steve Cirillo-Thompson</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196217-why-pharma-needs-chiefs-of-staff-with-steve-cirillo-thompson.mp3" length="25090776" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/t8g62w8i16qkxnoo99mbyuyn0f2n?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71yp4pr0</guid>
    <pubDate>Fri, 11 Oct 2024 11:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196217/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196217/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196217/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196217/transcript.vtt" type="text/vtt" />
    <itunes:duration>2087</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>10</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Achieving Work-Life Integration in Med Affairs with Jen Mohawk</itunes:title>
    <title>Achieving Work-Life Integration in Med Affairs with Jen Mohawk</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics.   They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires.   Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance.   They delve into practical strategies for integrat... Pharma Sess...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics.   They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires.   Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance.   They delve into practical strategies for integrat... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics.   They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires.   Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance.   They delve into practical strategies for integrat... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196218-achieving-work-life-integration-in-med-affairs-with-jen-mohawk.mp3" length="21825004" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/1jnbz98kypb7150cmb1midtki1n1?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">2099p9n0</guid>
    <pubDate>Fri, 16 Aug 2024 07:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196218/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196218/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196218/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196218/transcript.vtt" type="text/vtt" />
    <itunes:duration>1814</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>9</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Future Proofing Medical Affairs with Stephanie Hunter-Banks</itunes:title>
    <title>Future Proofing Medical Affairs with Stephanie Hunter-Banks</title>
    <itunes:summary><![CDATA[Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem.   Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies.   She reflects on her own career journey from pharmacy to leading learning ... Pharma...]]></itunes:summary>
    <description><![CDATA[Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem.   Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies.   She reflects on her own career journey from pharmacy to leading learning ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem.   Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies.   She reflects on her own career journey from pharmacy to leading learning ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196219-future-proofing-medical-affairs-with-stephanie-hunter-banks.mp3" length="25881366" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/nqrwr5ijcsrurimwvm5hkupd6ph4?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">815rvr40</guid>
    <pubDate>Mon, 10 Jun 2024 12:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196219/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196219/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196219/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196219/transcript.vtt" type="text/vtt" />
    <itunes:duration>2152</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>8</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Kaskey&#39;s Hierarchy of Needs for Medical Affairs with guest Stephen Dodge, SVP of Medical Affairs for Madrigal Pharmaceuticals</itunes:title>
    <title>Kaskey&#39;s Hierarchy of Needs for Medical Affairs with guest Stephen Dodge, SVP of Medical Affairs for Madrigal Pharmaceuticals</title>
    <itunes:summary><![CDATA[Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches  This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position.   Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies.   The discussion t... Pharma...]]></itunes:summary>
    <description><![CDATA[Kaskey&apos;s Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches  This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position.   Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies.   The discussion t... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Kaskey&apos;s Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches  This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position.   Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies.   The discussion t... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196220-kaskey-s-hierarchy-of-needs-for-medical-affairs-with-guest-stephen-dodge-svp-of-medical-affairs-for-madrigal-pharmaceuticals.mp3" length="27496270" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/9sb8wa2hr8qvdu81vstjomjtx8m2?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">m1jp9p41</guid>
    <pubDate>Tue, 09 Apr 2024 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196220/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196220/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196220/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196220/transcript.vtt" type="text/vtt" />
    <itunes:duration>2286</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>7</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Using Regulatory Processes to Enhance Patient Care: A Conversation with Lars Dreesmann</itunes:title>
    <title>Using Regulatory Processes to Enhance Patient Care: A Conversation with Lars Dreesmann</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.  They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies.   Lars shares his transition from academia to the pharmaceutical industry, the thrill ... P...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.  They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies.   Lars shares his transition from academia to the pharmaceutical industry, the thrill ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.  They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies.   Lars shares his transition from academia to the pharmaceutical industry, the thrill ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196221-using-regulatory-processes-to-enhance-patient-care-a-conversation-with-lars-dreesmann.mp3" length="27825901" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/nnt7cvk6xcyhanc50jzya379yd1b?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">j02r8rz0</guid>
    <pubDate>Wed, 06 Mar 2024 07:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196221/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196221/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196221/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196221/transcript.vtt" type="text/vtt" />
    <itunes:duration>2313</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>6</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Innovation in Medical Affairs: Embracing AI for Success with Scott Thompson</itunes:title>
    <title>Innovation in Medical Affairs: Embracing AI for Success with Scott Thompson</title>
    <itunes:summary><![CDATA[This episode is sponsored by Acceleration Point.  Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs.  Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements.   Scott encourages experimentation with secure, customized AI tools to improve output.  He outlines a case study where AI imp... Pharma Sessions ...]]></itunes:summary>
    <description><![CDATA[This episode is sponsored by Acceleration Point.  Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs.  Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements.   Scott encourages experimentation with secure, customized AI tools to improve output.  He outlines a case study where AI imp... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[This episode is sponsored by Acceleration Point.  Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs.  Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements.   Scott encourages experimentation with secure, customized AI tools to improve output.  He outlines a case study where AI imp... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196222-innovation-in-medical-affairs-embracing-ai-for-success-with-scott-thompson.mp3" length="23769272" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/fmhw4oiwielnbnp6xy6da850lhkp?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">41pqlqm0</guid>
    <pubDate>Sun, 04 Feb 2024 20:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196222/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196222/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196222/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196222/transcript.vtt" type="text/vtt" />
    <itunes:duration>1975</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>5</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Small Team, Big Impact: Life as The First MSL in a Biotech Startup with Orlando Granado-Balaez</itunes:title>
    <title>Small Team, Big Impact: Life as The First MSL in a Biotech Startup with Orlando Granado-Balaez</title>
    <itunes:summary><![CDATA[Life is different at a biotech. But is that a good thing?  Like so much in life, the answer is, "it depends."  On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies.   He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team.   Orlan... Pharma...]]></itunes:summary>
    <description><![CDATA[Life is different at a biotech. But is that a good thing?  Like so much in life, the answer is, &quot;it depends.&quot;  On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies.   He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team.   Orlan... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Life is different at a biotech. But is that a good thing?  Like so much in life, the answer is, &quot;it depends.&quot;  On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies.   He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team.   Orlan... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196223-small-team-big-impact-life-as-the-first-msl-in-a-biotech-startup-with-orlando-granado-balaez.mp3" length="21892568" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/gsbk1khqs654uuvvbjtgwzdc7cpk?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80nvwvv0</guid>
    <pubDate>Mon, 22 Jan 2024 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196223/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196223/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196223/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196223/transcript.vtt" type="text/vtt" />
    <itunes:duration>1818</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>4</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs</itunes:title>
    <title>The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs</title>
    <itunes:summary><![CDATA[The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs  In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health.   They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function.   On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced p... Pharma...]]></itunes:summary>
    <description><![CDATA[The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs  In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health.   They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function.   On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced p... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs  In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health.   They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function.   On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced p... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196224-the-science-of-sleep-exploring-its-role-in-performance-and-well-being-for-medical-affairs.mp3" length="34230402" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/ldgef6i50e1kae48hwfz3u0bveem?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">x16rvr71</guid>
    <pubDate>Tue, 02 Jan 2024 06:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196224/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196224/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196224/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196224/transcript.vtt" type="text/vtt" />
    <itunes:duration>2847</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>3</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Global Launch Excellence: Navigating Local and Global Challenges in Pharma with Jose Borbolla-Escoboza</itunes:title>
    <title>Global Launch Excellence: Navigating Local and Global Challenges in Pharma with Jose Borbolla-Escoboza</title>
    <itunes:summary><![CDATA[In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US.   Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&amp;n....]]></itunes:summary>
    <description><![CDATA[In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US.   Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&amp;n... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US.   Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&amp;n... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196225-global-launch-excellence-navigating-local-and-global-challenges-in-pharma-with-jose-borbolla-escoboza.mp3" length="21337430" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/luk4bdcrevpjoaoy10pvcjupj9bv?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">p1knvn70</guid>
    <pubDate>Tue, 12 Dec 2023 08:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196225/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196225/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196225/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196225/transcript.vtt" type="text/vtt" />
    <itunes:duration>1772</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The Art and Science of Negotiation in Medical Affairs</itunes:title>
    <title>The Art and Science of Negotiation in Medical Affairs</title>
    <itunes:summary><![CDATA[In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs.   Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen.  Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness.   Megan emphasizes the significance of maintaining a positive relationship with complian... Pharma...]]></itunes:summary>
    <description><![CDATA[In this episode of &quot;Pharma Sessions,&quot; host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs.   Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen.  Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness.   Megan emphasizes the significance of maintaining a positive relationship with complian... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of &quot;Pharma Sessions,&quot; host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs.   Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen.  Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness.   Megan emphasizes the significance of maintaining a positive relationship with complian... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196226-the-art-and-science-of-negotiation-in-medical-affairs.mp3" length="23306279" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/3gi7v15lkfz2j91xtfcr66dk1h2o?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71v5n570</guid>
    <pubDate>Mon, 30 Oct 2023 06:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196226/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196226/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196226/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196226/transcript.vtt" type="text/vtt" />
    <itunes:duration>1939</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Gene Therapy Breakthroughs: Exploring the Crucial Role of Medical Affairs with Dr. Huma Qamar</itunes:title>
    <title>Gene Therapy Breakthroughs: Exploring the Crucial Role of Medical Affairs with Dr. Huma Qamar</title>
    <itunes:summary><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.  With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you'll learn:   1. The importance of patient-centered outcomes re...]]></itunes:summary>
    <description><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.  With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you&apos;ll learn:   1. The importance of patient-centered outcomes re... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.  With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you&apos;ll learn:   1. The importance of patient-centered outcomes re... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196227-gene-therapy-breakthroughs-exploring-the-crucial-role-of-medical-affairs-with-dr-huma-qamar.mp3" length="25293565" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/fysragnmkey3yraoc9ane8e1e69v?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">61mkmkv1</guid>
    <pubDate>Tue, 03 Oct 2023 18:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196227/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196227/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196227/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196227/transcript.vtt" type="text/vtt" />
    <itunes:duration>2103</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Unlocking Potential: Hidden Data and Disparities in Clinical Trial Participation</itunes:title>
    <title>Unlocking Potential: Hidden Data and Disparities in Clinical Trial Participation</title>
    <itunes:summary><![CDATA[Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.  Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training.  Top 5 learnings from the episode:   The critical need for data shar...]]></itunes:summary>
    <description><![CDATA[Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.  Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training.  Top 5 learnings from the episode:   The critical need for data shar... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.  Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training.  Top 5 learnings from the episode:   The critical need for data shar... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196228-unlocking-potential-hidden-data-and-disparities-in-clinical-trial-participation.mp3" length="25992447" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/huyobl0vo3ifmask54co6ay8q9hv?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80q3j3n0</guid>
    <pubDate>Wed, 12 Jul 2023 11:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196228/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196228/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196228/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196228/transcript.vtt" type="text/vtt" />
    <itunes:duration>2161</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>14</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>4 Medical Affairs Hacks for Time Management</itunes:title>
    <title>4 Medical Affairs Hacks for Time Management</title>
    <itunes:summary><![CDATA[In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals.   From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out.   Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals.   Tune in now to master the art of time management and increase you... Pharma Sess...]]></itunes:summary>
    <description><![CDATA[In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals.   From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out.   Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals.   Tune in now to master the art of time management and increase you... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals.   From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out.   Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals.   Tune in now to master the art of time management and increase you... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196229-4-medical-affairs-hacks-for-time-management.mp3" length="24989952" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/58k3pzvbmqfmf5b7nm4b6oc3e6jt?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">713rw3j0</guid>
    <pubDate>Fri, 23 Jun 2023 10:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196229/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196229/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196229/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196229/transcript.vtt" type="text/vtt" />
    <itunes:duration>2079</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>13</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>The 4 R&#39;s of Medical Information with Tim Fish</itunes:title>
    <title>The 4 R&#39;s of Medical Information with Tim Fish</title>
    <itunes:summary><![CDATA[We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.  Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training &amp; Development at Alkermes. Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and responding to inquiries, reviewing content, and researching answers in medical...]]></itunes:summary>
    <description><![CDATA[We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.  Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training &amp; Development at Alkermes. Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and responding to inquiries, reviewing content, and researching answers in medical... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.  Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training &amp; Development at Alkermes. Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and responding to inquiries, reviewing content, and researching answers in medical... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196230-the-4-r-s-of-medical-information-with-tim-fish.mp3" length="18394807" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/w5s1y2jjdjck5mqmbj0jrp69z2vr?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">l14rl4w1</guid>
    <pubDate>Mon, 22 May 2023 08:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196230/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196230/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196230/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196230/transcript.vtt" type="text/vtt" />
    <itunes:duration>1529</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>12</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Improving Diversity in Clinical Trials: Challenges and Solutions</itunes:title>
    <title>Improving Diversity in Clinical Trials: Challenges and Solutions</title>
    <itunes:summary><![CDATA[This episode is the second in Pharma Sessions' series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective. Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research. Starting as a research assistant, working her way up to study coordinator and cl...]]></itunes:summary>
    <description><![CDATA[This episode is the second in Pharma Sessions&apos; series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective. Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research. Starting as a research assistant, working her way up to study coordinator and cl...<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[This episode is the second in Pharma Sessions&apos; series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective. Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research. Starting as a research assistant, working her way up to study coordinator and cl...<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196231-improving-diversity-in-clinical-trials-challenges-and-solutions.mp3" length="16078776" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/kues7eyeo70yikv3javhgaf9jnlm?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">71wjwxw0</guid>
    <pubDate>Thu, 04 May 2023 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196231/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196231/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196231/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196231/transcript.vtt" type="text/vtt" />
    <itunes:duration>1336</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>11</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Preparing Field Medical for Launch: Challenges and Strategies for Pharma Companies</itunes:title>
    <title>Preparing Field Medical for Launch: Challenges and Strategies for Pharma Companies</title>
    <itunes:summary><![CDATA[In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like? I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations. In addition to being a certified speaker, trainer and coach as well as a podcaster, Tom is the founder of an Executive Search Firm called The Carolan Group. They’re known for their niche expertise for specializing in the recruitment and placement of highly s...]]></itunes:summary>
    <description><![CDATA[In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like? I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations. In addition to being a certified speaker, trainer and coach as well as a podcaster, Tom is the founder of an Executive Search Firm called The Carolan Group. They’re known for their niche expertise for specializing in the recruitment and placement of highly s... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like? I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations. In addition to being a certified speaker, trainer and coach as well as a podcaster, Tom is the founder of an Executive Search Firm called The Carolan Group. They’re known for their niche expertise for specializing in the recruitment and placement of highly s... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196232-preparing-field-medical-for-launch-challenges-and-strategies-for-pharma-companies.mp3" length="26296884" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/pgj4jngbyd0o0zic0ykcg120v6qu?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">v07r6yq1</guid>
    <pubDate>Sun, 16 Apr 2023 21:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196232/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196232/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196232/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196232/transcript.vtt" type="text/vtt" />
    <itunes:duration>2187</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>10</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Navigating the Evolving Landscape of Medical Affairs with Steve Royle</itunes:title>
    <title>Navigating the Evolving Landscape of Medical Affairs with Steve Royle</title>
    <itunes:summary><![CDATA[Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry.  After starting in sales and marketing, Steve moved to the agency side of global medical communications and medical education. He went on to found Swipe Health and Rumi. Recently, Steve has used his expertise to create mymedicalafairs.com, a Netflix-style database of medical affairs events and topics.   Through mymedicalaffairs.com, we crowdsourc... Pharma...]]></itunes:summary>
    <description><![CDATA[Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry.  After starting in sales and marketing, Steve moved to the agency side of global medical communications and medical education. He went on to found Swipe Health and Rumi. Recently, Steve has used his expertise to create mymedicalafairs.com, a Netflix-style database of medical affairs events and topics.   Through mymedicalaffairs.com, we crowdsourc... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry.  After starting in sales and marketing, Steve moved to the agency side of global medical communications and medical education. He went on to found Swipe Health and Rumi. Recently, Steve has used his expertise to create mymedicalafairs.com, a Netflix-style database of medical affairs events and topics.   Through mymedicalaffairs.com, we crowdsourc... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196233-navigating-the-evolving-landscape-of-medical-affairs-with-steve-royle.mp3" length="24336362" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/ldxcrqnf6hr0jzzk8ghpemhfyehd?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">k08yq981</guid>
    <pubDate>Fri, 31 Mar 2023 10:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196233/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196233/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196233/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196233/transcript.vtt" type="text/vtt" />
    <itunes:duration>2025</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>7</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Increasing Clinical Trial Diversity with Camille Pope, Chief Medical Lead at Acclinate</itunes:title>
    <title>Increasing Clinical Trial Diversity with Camille Pope, Chief Medical Lead at Acclinate</title>
    <itunes:summary><![CDATA[Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.  She'd previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles. We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of trial diversity can have when presenting information to patients and provide...]]></itunes:summary>
    <description><![CDATA[Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.  She&apos;d previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles. We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of trial diversity can have when presenting information to patients and provide... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.  She&apos;d previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles. We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of trial diversity can have when presenting information to patients and provide... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196234-increasing-clinical-trial-diversity-with-camille-pope-chief-medical-lead-at-acclinate.mp3" length="24737922" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/oyqeaus9n3ki7f748883ppn5oign?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">z1r42z51</guid>
    <pubDate>Wed, 22 Mar 2023 06:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196234/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196234/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196234/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196234/transcript.vtt" type="text/vtt" />
    <itunes:duration>2056</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Why Medical Affairs Needs To Care About LinkedIn</itunes:title>
    <title>Why Medical Affairs Needs To Care About LinkedIn</title>
    <itunes:summary><![CDATA[Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their launchpad. In this episode Chris talks about how to use social media, specifically LinkedIn. He discusses the benefits of having a strong online brand and how to make it stand out. Chris and Jon talk give examples about using social not only for personal br...]]></itunes:summary>
    <description><![CDATA[Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their launchpad. In this episode Chris talks about how to use social media, specifically LinkedIn. He discusses the benefits of having a strong online brand and how to make it stand out. Chris and Jon talk give examples about using social not only for personal br... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their launchpad. In this episode Chris talks about how to use social media, specifically LinkedIn. He discusses the benefits of having a strong online brand and how to make it stand out. Chris and Jon talk give examples about using social not only for personal br... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196235-why-medical-affairs-needs-to-care-about-linkedin.mp3" length="21299105" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/4dzzosp3a780wrp0xomlduzn49b8?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">80znqx80</guid>
    <pubDate>Mon, 06 Mar 2023 10:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196235/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196235/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196235/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196235/transcript.vtt" type="text/vtt" />
    <itunes:duration>1768</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>7</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Digital Med Affairs Strategy with Eddie Power, VP Medical Affairs, Pfizer</itunes:title>
    <title>Digital Med Affairs Strategy with Eddie Power, VP Medical Affairs, Pfizer</title>
    <itunes:summary><![CDATA[Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com   ]]></itunes:summary>
    <description><![CDATA[Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Pharma Sessions is hosted by Jonathan Kaskey  Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/  Or join the Pharma Sessions Substack: www.pharmasessions.substack.com <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196236-digital-med-affairs-strategy-with-eddie-power-vp-medical-affairs-pfizer.mp3" length="26672592" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/tkojebp9vmpp2ifcc6iujeu96g4x?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">81x2zx41</guid>
    <pubDate>Wed, 18 Jan 2023 11:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196236/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196236/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196236/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196236/transcript.vtt" type="text/vtt" />
    <itunes:duration>2217</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Standing in Success with Evan Reddick, AVP and Head of Global Medical Affairs Strategy at Menarini Stemline</itunes:title>
    <title>Standing in Success with Evan Reddick, AVP and Head of Global Medical Affairs Strategy at Menarini Stemline</title>
    <itunes:summary><![CDATA[Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy.  Evan previously had a number of field and leadership roles at a large pharma. A highlight was the very first topic discussed, the framework of “Standing in Success”, and what that means for leaders. But we covered so much, I'm really excited to hear what you ha... P...]]></itunes:summary>
    <description><![CDATA[Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy.  Evan previously had a number of field and leadership roles at a large pharma. A highlight was the very first topic discussed, the framework of “Standing in Success”, and what that means for leaders. But we covered so much, I&apos;m really excited to hear what you ha... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Evan Reddick recently joined an exciting emerging biotech with a major phase 3 trial win, and preparing to launch a first-in-class oral medication for breast cancer, serving as the AVP and Head of Global Medical Affairs Strategy.  Evan previously had a number of field and leadership roles at a large pharma. A highlight was the very first topic discussed, the framework of “Standing in Success”, and what that means for leaders. But we covered so much, I&apos;m really excited to hear what you ha... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196237-standing-in-success-with-evan-reddick-avp-and-head-of-global-medical-affairs-strategy-at-menarini-stemline.mp3" length="20052873" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/fuuqa88smt6wuzo3kv2cyvixy77e?.jpg" />
    <itunes:author>Jon Kaskey, Digital Enthusiast</itunes:author>
    <guid isPermaLink="false">x0l6jzm0</guid>
    <pubDate>Wed, 21 Dec 2022 06:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196237/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196237/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196237/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196237/transcript.vtt" type="text/vtt" />
    <itunes:duration>1665</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>HEOR with Riad Dirani, Vice President, Global Health Economics and Outcomes Research at Teva Pharmaceuticals</itunes:title>
    <title>HEOR with Riad Dirani, Vice President, Global Health Economics and Outcomes Research at Teva Pharmaceuticals</title>
    <itunes:summary><![CDATA[Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals.  We talk about:  Customizing data for a global audienceThe importance of a clear medical storyHow to create an insights gathering process that turns a scientific narrative into a living documentHow HEOR can best support a field teamInvolving Medical Directors in RWE generationWhat's needed to create "1 medical team" as a mindsetWhat the future holds for HEORThe views expressed here are mine and Riad's, and don’t reflect t... Pharma...]]></itunes:summary>
    <description><![CDATA[Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals.  We talk about:  Customizing data for a global audienceThe importance of a clear medical storyHow to create an insights gathering process that turns a scientific narrative into a living documentHow HEOR can best support a field teamInvolving Medical Directors in RWE generationWhat&apos;s needed to create &quot;1 medical team&quot; as a mindsetWhat the future holds for HEORThe views expressed here are mine and Riad&apos;s, and don’t reflect t... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Riad Dirani is the VP of Global HEOR at Teva Pharmaceuticals.  We talk about:  Customizing data for a global audienceThe importance of a clear medical storyHow to create an insights gathering process that turns a scientific narrative into a living documentHow HEOR can best support a field teamInvolving Medical Directors in RWE generationWhat&apos;s needed to create &quot;1 medical team&quot; as a mindsetWhat the future holds for HEORThe views expressed here are mine and Riad&apos;s, and don’t reflect t... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196238-heor-with-riad-dirani-vice-president-global-health-economics-and-outcomes-research-at-teva-pharmaceuticals.mp3" length="25386243" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/cdywmtthsqcq1d2b1obcitwxkqw9?.jpg" />
    <itunes:author>Jon Kaskey, Digital Enthusiast</itunes:author>
    <guid isPermaLink="false">70yp4xr1</guid>
    <pubDate>Wed, 30 Nov 2022 07:00:00 -0500</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196238/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196238/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196238/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196238/transcript.vtt" type="text/vtt" />
    <itunes:duration>2110</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Patient Journey with Amber Spierer, VP Patient Affairs at EQRx</itunes:title>
    <title>Patient Journey with Amber Spierer, VP Patient Affairs at EQRx</title>
    <itunes:summary><![CDATA[Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis. We talk about:  Defining the patient journeyWhy understanding this journey is important strategicallyThe difference between viewing someone as a patient and as a personCurrent patient expectations around working with pharmaTacticsThe views expressed here are mine and Amber’s, and don’t reflect those of our employers.  Pharma Sessions is hosted by Jonathan Kaskey  Follow along on ... Pharma ...]]></itunes:summary>
    <description><![CDATA[Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis. We talk about:  Defining the patient journeyWhy understanding this journey is important strategicallyThe difference between viewing someone as a patient and as a personCurrent patient expectations around working with pharmaTacticsThe views expressed here are mine and Amber’s, and don’t reflect those of our employers.  Pharma Sessions is hosted by Jonathan Kaskey  Follow along on ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis. We talk about:  Defining the patient journeyWhy understanding this journey is important strategicallyThe difference between viewing someone as a patient and as a personCurrent patient expectations around working with pharmaTacticsThe views expressed here are mine and Amber’s, and don’t reflect those of our employers.  Pharma Sessions is hosted by Jonathan Kaskey  Follow along on ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196239-patient-journey-with-amber-spierer-vp-patient-affairs-at-eqrx.mp3" length="18779255" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/rygho1c3t1vlc2sizuw3o1is39mo?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">2199p5n1</guid>
    <pubDate>Mon, 17 Oct 2022 10:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196239/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196239/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196239/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196239/transcript.vtt" type="text/vtt" />
    <itunes:duration>1559</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>3</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics</itunes:title>
    <title>Adoption, Insights and Patient Engagement with Pete Piliero, VP Med Affairs at Melinta Therapeutics</title>
    <itunes:summary><![CDATA[I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics. We talk about:  Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairsThe differences between access and adoption (and how to impact both)Advances in patient engagement and much moreA quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.  At one point I reference the MAPS, Future of Medical Affairs report. You ... P...]]></itunes:summary>
    <description><![CDATA[I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics. We talk about:  Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairsThe differences between access and adoption (and how to impact both)Advances in patient engagement and much moreA quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.  At one point I reference the MAPS, Future of Medical Affairs report. You ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics. We talk about:  Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairsThe differences between access and adoption (and how to impact both)Advances in patient engagement and much moreA quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.  At one point I reference the MAPS, Future of Medical Affairs report. You ... <p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196240-adoption-insights-and-patient-engagement-with-pete-piliero-vp-med-affairs-at-melinta-therapeutics.mp3" length="20885814" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/nk7j9xigk3c7lqskxyc3vvvpypas?.jpg" />
    <itunes:author>Jonathan Kaskey</itunes:author>
    <guid isPermaLink="false">805rvw41</guid>
    <pubDate>Thu, 15 Sep 2022 09:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196240/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196240/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196240/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196240/transcript.vtt" type="text/vtt" />
    <itunes:duration>1735</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>2</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
  <item>
    <itunes:title>Medical Affairs Leadership with Danie du Plessis, EVP of Medical Affairs at Kyowa Kirin</itunes:title>
    <title>Medical Affairs Leadership with Danie du Plessis, EVP of Medical Affairs at Kyowa Kirin</title>
    <itunes:summary><![CDATA[Danie du Plessis is the EVP of Medical Affairs for Kyowa Kirin, a board member at the Medical Affairs Professional Society, and was previously the SVP of Global Medical Affairs for GSK.   We talk about:  Why Danie switched from primary care to working with pharmaIf a business background is important in med affairs leadershipLeading big organizations vs small organizationsHow important an understanding of the patient journey is to everything med affairsPharma Sessions is hosted by Jo...Pharma ...]]></itunes:summary>
    <description><![CDATA[Danie du Plessis is the EVP of Medical Affairs for Kyowa Kirin, a board member at the Medical Affairs Professional Society, and was previously the SVP of Global Medical Affairs for GSK.   We talk about:  Why Danie switched from primary care to working with pharmaIf a business background is important in med affairs leadershipLeading big organizations vs small organizationsHow important an understanding of the patient journey is to everything med affairsPharma Sessions is hosted by Jo...<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></description>
    <content:encoded><![CDATA[Danie du Plessis is the EVP of Medical Affairs for Kyowa Kirin, a board member at the Medical Affairs Professional Society, and was previously the SVP of Global Medical Affairs for GSK.   We talk about:  Why Danie switched from primary care to working with pharmaIf a business background is important in med affairs leadershipLeading big organizations vs small organizationsHow important an understanding of the patient journey is to everything med affairsPharma Sessions is hosted by Jo...<p>Pharma Sessions is hosted by Jonathan Kaskey<br/><br/>Follow along on LinkedIn: <a href='https://www.linkedin.com/in/jonkaskey/'>https://www.linkedin.com/in/jonkaskey/</a><br/><br/>Or join the Pharma Sessions Substack:<br/><a href='https://pharmasessions.substack.com/'>www.pharmasessions.substack.com<br/></a><br/></p>]]></content:encoded>
    <enclosure url="https://www.buzzsprout.com/2039560/episodes/19196241-medical-affairs-leadership-with-danie-du-plessis-evp-of-medical-affairs-at-kyowa-kirin.mp3" length="17179564" type="audio/mpeg" />
    <itunes:image href="https://storage.buzzsprout.com/tafviww8yvucw8t2bvqjvr2dmotd?.jpg" />
    <itunes:author>Jon</itunes:author>
    <guid isPermaLink="false">m0jp9z40</guid>
    <pubDate>Wed, 24 Aug 2022 07:00:00 -0400</pubDate>
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196241/transcript" type="text/html" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196241/transcript.json" type="application/json" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196241/transcript.srt" type="application/x-subrip" />
    <podcast:transcript url="https://www.buzzsprout.com/2039560/19196241/transcript.vtt" type="text/vtt" />
    <itunes:duration>1426</itunes:duration>
    <itunes:keywords></itunes:keywords>
    <itunes:episode>1</itunes:episode>
    <itunes:episodeType></itunes:episodeType>
    <itunes:explicit>false</itunes:explicit>
  </item>
</channel>
</rss>
